ClinicalTrials.Veeva

Menu

Safety/Efficacy Study of Restylane® in Lip Augmentation

M

Medicis Global Service

Status

Completed

Conditions

Lip Augmentation

Treatments

Device: Restylane®
Device: Non-Treatment

Study type

Interventional

Funder types

Industry

Identifiers

NCT00935272
MA-1300-15

Details and patient eligibility

About

To determine the safety and effectiveness of Restylane® when used for lip augmentation.

Enrollment

180 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must meet established lip fullness criteria

Exclusion criteria

  • Allergic to injectable hyaluronic acid, local topical anesthetics or nerve blocking agents; Conditions/procedures that could interfere with lip fullness evaluations

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

180 participants in 2 patient groups

Treatment
Experimental group
Description:
Restylane® Treatment
Treatment:
Device: Restylane®
Non-Treatment
No Intervention group
Description:
Non-Treatment Arm
Treatment:
Device: Non-Treatment

Trial contacts and locations

12

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems